DocGo Inc. Employee Benefits and Share-based Compensation
DocGo Inc. (DCGO) reported Employee Benefits and Share-based Compensation of $4.62 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Compensation Related Costs › General
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2022-11-08
- DocGo Inc. employee benefits and share-based compensation for the quarter ending 2022-09-30 was $1.11M, a 139.98% increase year-over-year.
- DocGo Inc. employee benefits and share-based compensation for the quarter ending 2022-06-30 was $2.08M, a 462.68% increase year-over-year.
- DocGo Inc. employee benefits and share-based compensation for the quarter ending 2022-03-31 was $1.42M, a 263.43% increase year-over-year.
- DocGo Inc. employee benefits and share-based compensation for the quarter ending 2021-12-31 was $151.77K.
- DocGo Inc. employee benefits and share-based compensation for fiscal 2021 was $1.38M, a 100.32% increase from fiscal 2020.
- DocGo Inc. employee benefits and share-based compensation for fiscal 2020 was $687.07K.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|
| 2022-09-30 | $1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $3.19M derived: sum of 2 quarters · filed 2022-11-08 | $4.62M 10-Q · filed 2022-11-08 | $4.77M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $3.50M 10-Q · filed 2022-08-09 | $3.66M derived: sum of 3 quarters · filed 2022-08-09 | $4.12M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $1.42M 10-Q · filed 2022-05-10 | $1.57M derived: sum of 2 quarters · filed 2022-05-10 | $2.04M derived: sum of 3 quarters · filed 2022-11-08 | $2.41M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | $151.77K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $614.82K derived: sum of 2 quarters · filed 2022-11-08 | $984.82K derived: sum of 3 quarters · filed 2022-11-08 | $1.38M 10-K · filed 2022-03-15 |
| 2021-09-30 | $463.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $833.05K derived: sum of 2 quarters · filed 2022-11-08 | $1.22M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $370.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $761.53K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $391.53K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $687.07K 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |